| Literature DB >> 30936633 |
Ernest Kwesi Ofori1, Emmanuel Frimpong2, Adeolu Ademiluyi1, Olajide Ayinla Olawale3.
Abstract
[Purpose] The aim of this study was to assess the effects of ergometer cycling on the ambulatory function and cardiovascular fitness of patients with stroke in the sub-acute phase. [Participants and Methods] Twenty (20) patients with stroke in the sub-acute phase were randomly allocated to either an ergometer cycling group (n=10) or a control group (n=10). The experimental (ergometer cycling) group performed cycling exercises in addition to conventional physiotherapy for 60 minutes per session, three times per week for 8 weeks. The control group only received conventional physiotherapy for the same duration as the experimental group. Assessments of participants' functional ambulatory category, ambulatory velocity, 6-minute walk test, heart rate and blood pressure were conducted at baseline and at the end of the 8-week intervention.Entities:
Keywords: Ambulatory function; Ergometer cycling; Stroke
Year: 2019 PMID: 30936633 PMCID: PMC6428648 DOI: 10.1589/jpts.28.211
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Fig. 1.Flow chart of the study design
Characteristics of the study participants
| Characteristics | ErCG | CG | |
|---|---|---|---|
| N (%) | 10 (50) | 10 (50) | |
| Age (Mean ± SD) (years) | 58.8 ± 8.3 | 62.4 ± 8.8 | |
| Duration of stroke (Mean ± SD) (months) | 3.5 ± 2.6 | 4.1 ± 3.0 | |
| Type of stroke n (%) | |||
| Ischaemic | 9 (45) | 7 (35) | |
| Haemorrhagic | 2 (10) | 2 (10) | |
| Side of stroke n (%) | |||
| Left | 5 (25) | 5 (25) | |
| Right | 5 (25) | 5 (25) | |
N: number of participants; %: percentage; ErCG: ergometer cycling group; CG: control group; Mean ± SD: mean plus or minus standard deviation
Comparison of outcome measures between and within ErCG and CG at both baseline and week 8
| Outcome measure | ErCG (Mean ± SD) | CG (Mean ± SD) | |
|---|---|---|---|
| FAC | |||
| Baseline | 2.8 ± 0.6 | 2.9 ± 0.7 | |
| Week 8 | 4.0 ± 0.8# | 3.1 ± 1.3 | |
| AV (m/s) | |||
| Baseline | 0.64 ± 0.18* | 0.46 ± 0.22 | |
| Week 8 | 0.74 ± 0.18#* | 0.49 ± 0.24 | |
| 6-MWT (m) | |||
| Baseline | 278.7 ± 58.06 | 251.7 ± 56.1 | |
| Week 8 | 310.6 ± 63.9#* | 268.5 ± 55.1 | |
| HR (bpm) | |||
| Baseline | 75.0 ± 9.1 | 81.2 ± 4.0 | |
| Week 8 | 72.3 ± 6.3* | 79.3 ± 1.9 | |
| SBP (mmHg) | |||
| Baseline | 133.9 ± 12.2 | 134.0 ± 8.1 | |
| Week 8 | 123.0 ± 7.4#* | 133.1 ± 8.3 | |
| DBP (mmHg) | |||
| Baseline | 82.0 ± 7.2 | 83.6 ± 7.5 | |
| Week 8 | 73.2 ± 9.0#* | 81.8 ± 8.7 | |
ErCG: ergometer cycling group; CG: control group; FAC: functional ambulatory category; AV: ambulatory velocity; 6-MWT: 6-Minute Walk Test; HR: heart rate; bpm: beats per minute; SBP: systolic blood pressure; DBP: diastolic blood pressure; mmHg: millimetres of Mercury; Mean ± SD: mean plus or minus standard deviation. *significant differences in outcome measures between ErCG and CG at both baseline and week 8. #significant differences in outcome measures from baseline to week 8 in ErCG.